Star Sports Medicine Co., Ltd. (HKG:1609)
Hong Kong · Delayed Price · Currency is HKD 143.80
-0.30 (-0.21%)
Aug 21, 2026, 4:08 PM HKT
Star Sports Medicine Revenue
In the year 2025, Star Sports Medicine had annual revenue of 402.75M CNY with 23.12% growth. Star Sports Medicine had revenue of 35.04M in the quarter ending March 31, 2023.
Revenue
402.75M CNY
Revenue Growth
+23.12%
P/S Ratio
17.59
Revenue / Employee
1.32M CNY
Employees
305
Market Cap
7.88B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 402.75M | 75.63M | 23.12% |
| Dec 31, 2024 | 327.12M | 88.58M | 37.13% |
| Dec 31, 2023 | 238.54M | 90.57M | 61.21% |
| Dec 31, 2022 | 147.97M | 74.96M | 102.66% |
| Dec 31, 2021 | 73.01M | 46.61M | 176.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| MicroPort Scientific | 8.60B |
| China Isotope & Radiation | 8.00B |
| Modern Dental Group | 3.74B |
| AK Medical Holdings | 1.65B |
| LifeTech Scientific | 1.52B |
| Zylox-Tonbridge Medical Technology | 1.18B |
| Beijing Chunlizhengda Medical Instruments | 1.17B |
| MicroPort NeuroScientific | 879.66M |
Star Sports Medicine News
- 4 days ago - Star Sports Medicine Earnings release: Q2 2026 - Filings